Healthcare -
Biotechnology - NASDAQ - US
$ 1.63
3.82 %
$ 248 M
Market Cap
-10.19
P/E
HRTX - LONG-TERM DEBT
Long-term Debt HRTX - Heron Therapeutics, Inc.
177 M
LAST VALUE
6.02%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR